Inside UnitedHealth Group’s Defense Of $3.3B Amedisys Acquisition

Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the case closer to trial and shed more light on how UnitedHealth and Amedisys are pursuing divestments and defending the transaction. First, UnitedHealth dropped its motion to dismiss the case, saying that the […]

Future Of Wound Care: Home Health Providers Step Up To Meet Rising Demand

As home health providers increasingly serve people with more complicated and serious conditions, and the push for cost-effective and value-based care continues, wound care is becoming more important than ever. The good news is that technology is changing the game for at-home wound care, but the bad news is that serious challenges remain regarding access […]

How Amedisys, SSM Achieve Success With Disease-Specific Care Models

As the demand for personalized and effective health care solutions grows, home health care providers are implementing more sophisticated approaches to particular diseases. Today, home health care professionals can manage conditions such as strokes, heart failure and cancer, achieving successful patient outcomes and bottom-line benefits; however, reimbursement cuts pose a challenge. “We determine which conditions […]

Top Home Health Trends For 2025

The year ahead will be a fascinating one in home health care. As 2025 dawns, the industry faces many uncertainties, and the next 12 months will be pivotal in shaping the future. Regulatory decisions will have an outsized impact on home health providers in the near-term, and their effects could stretch well into the future. […]

VitalCaring Deal Reportedly Suspended As UnitedHealth, Amedisys Seek Path Forward

Amedisys’ (Nasdaq: AMED) planned divestiture of more than 100 home health and hospice locations to VitalCaring has reportedly been halted following a federal court ruling that requires Texas-based VitalCaring to allocate a significant portion of its future profits to Encompass Health and Enhabit. Amedisys in June announced an agreement to sell some of its locations […]

Inside the Future Of Contessa Health And High-Acuity Care at Home 

When Amedisys Inc. (Nasdaq: AMED) acquired Contessa Health for $250 million in 2021, it changed the home-based care landscape. While other companies had been toying with high-acuity care in the home, that deal sent a clear message: Home-based care was becoming more than just Medicare-certified home health care and personal care services. Since that point, […]

The Top 10 Home Health Care News Stories Of 2024

Major deals hit snags. Home health cuts continued. Regulatory noise came in from all sides, in Medicare and in Medicaid. All of those realities made their way into Home Health Care News’ most popular stories for the year. In order to summarize the 2024 that providers had, HHCN is revisiting 10 of its most widely […]

VitalCaring Rebuts The DOJ, Makes Case For Itself As Worthy Divestment Partner 

VitalCaring Group – the home health and hospice company led by April Anthony – got caught in the crosshairs of the U.S. Department of Justice (DOJ) this week. The company responded, however, defending its current state and re-emphasizing where it plans to go. VitalCaring agreed to acquire divested assets from Amedisys Inc. (Nasdaq: AMED) in […]

Evaluating The DOJ’s Arguments Against The UnitedHealth Group-Amedisys Deal

The U.S. Department of Justice (DOJ) and four state attorneys general filed a lawsuit to block UnitedHealth Group’s (NYSE: UNH) acquisition of Amedisys (Nasdaq: AMED) this week. The DOJ’s complaint is thorough, with some compelling arguments, and some less so. Home health veterans have been predicting consolidation of the fragmented industry for a long time. […]